Brief: Freeline Initiates Dosing Of Second Cohort In Marvel-1 Trial Of Flt190 Gene Therapy Candidate For People With Fabry Disease

Freeline Therapeutics Holdings

04/10/2022 12:17

Oct 4 (Reuters) - Freeline Therapeutics Holdings PLC
 FRLN.O :
    * FREELINE INITIATES DOSING OF SECOND COHORT IN MARVEL-1
TRIAL OF
FLT190 GENE THERAPY CANDIDATE FOR PEOPLE WITH FABRY DISEASE

Source text for Eikon:  ID:nGNX6Y6vYz 
Further company coverage:  FRLN.O 
 (Reuters.Briefs@thomsonreuters.com;)
 ((Reuters.Briefs@thomsonreuters.com;))